Clinico-pathological and Genomic Features of HER2-low Early Breast Cancer

Clinical trial NCT07561346 · COMPLETED

Trial details

NCT number: NCT07561346
Sponsor: Hellenic Cooperative Oncology Group
Status: COMPLETED
Study type: OBSERVATIONAL

HER2-zero, HER2-low and HER2-positive Tumors Distribution Across HR Expression Categories

Start date: 1996-12-10
Primary completion: 2026-07-07
Enrollment: 3648

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.